Hypertension Clinical Trials in Rio de Janeiro
5 recruitingRio de Janeiro, Brazil
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension
Endothelial DysfunctionArterial HypertensionResistant Hypertension+1 more
National Institute of Cardiology, Laranjeiras, Brazil150 enrolled1 locationNCT05464849
Recruiting
Early Phase 1
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Arterial HypertensionMicrovascular FunctionResistant Hypertension+1 more
National Institute of Cardiology, Laranjeiras, Brazil50 enrolled1 locationNCT06169241
Recruiting
Not Applicable
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
HypertensionInflammationCardiovascular Diseases (CVD)
Universidade Federal Fluminense34 enrolled1 locationNCT06917131